Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement function in mAb-mediated cancer immunotherapy.

× No keyword cloud information.

68 in total

1. Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.

Authors: Bing Li; Daniel J Allendorf; Richard Hansen; Jose Marroquin; Daniel E Cramer; Claire L Harris; Jun Yan
Journal: Cancer Res Date: 2007-08-01 Impact factor: 12.701

2. NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

Authors: Siao-Yi Wang; Emilian Racila; Ronald P Taylor; George J Weiner
Journal: Blood Date: 2007-11-16 Impact factor: 22.113

Review 3. Protein engineering to target complement evasion in cancer.

Authors: Darrick Carter; André Lieber
Journal: FEBS Lett Date: 2013-11-14 Impact factor: 4.124

4. FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.

Authors: Carole Seguin-Devaux; Jean-Marc Plesseria; Charlène Verschueren; Cécile Masquelier; Gilles Iserentant; Marie Fullana; Mihály Józsi; Jacques H M Cohen; Xavier Dervillez
Journal: Mol Oncol Date: 2019-09-30 Impact factor: 6.603

Review 5. Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.

Authors: Michael Campoli; Robert Ferris; Soldano Ferrone; Xinhui Wang
Journal: Clin Cancer Res Date: 2009-12-22 Impact factor: 12.531

Review 6. Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors: Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal: Nat Rev Clin Oncol Date: 2020-02-17 Impact factor: 66.675

Review 7. The dual role of complement in cancer and its implication in anti-tumor therapy.

Authors: Ioannis Kourtzelis; Stavros Rafail
Journal: Ann Transl Med Date: 2016-07

8. Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.

Authors: Carolina Salvador; Bing Li; Richard Hansen; Daniel E Cramer; Maiying Kong; Jun Yan
Journal: Clin Cancer Res Date: 2008-02-15 Impact factor: 12.531

9. Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC.

Authors: Akito Natsume; Rinpei Niwa; Mitsuo Satoh
Journal: Drug Des Devel Ther Date: 2009-09-21 Impact factor: 4.162

10. Commandeering a biological pathway using aptamer-derived molecular adaptors.

Authors: Prabhat K Mallik; Kimi Nishikawa; Albert J T Millis; Hua Shi
Journal: Nucleic Acids Res Date: 2010-01-06 Impact factor: 16.971